Search
-
Lymphoma Specialist
Jennifer Lue is a medical oncologist and hematologist specializing in lymphoma, including non-Hodgkin and Hodgkin lymphoma.
… Lymphoma Specialist & Cellular Therapist Job Title Clinical Director, Lymphoma Service I am a medical oncologist and hematologist dedicated to caring for people with lymphoma, including non-Hodgkin and Hodgkin lymphoma. As a member of MSK’s Division of Hematologic Oncology, my goal is to provide unparalleled
-
Lymphoma Specialist
Jennifer Lue es oncóloga médica y hematóloga especializada en linfomas, incluidos los linfomas no hodgkinianos y la enfermedad de Hodgkin.
… Lymphoma Specialist Job Title Directora Clínica del Servicio de Linfoma Soy oncóloga médica y hematóloga dedicada al cuidado de personas con linfoma, incluido el linfoma no hodgkiniano y la enfermedad de Hodgkin. Como miembro de la División de Oncología Hematológica de MSK, mi objetivo es brindar una
-
Clinical Trial
… Full Title A Randomized Phase II, Double-Blind, Multicenter Study Evaluating the Efficacy and Safety of Autogene Cevumeran Plus Nivolumab Versus Nivolumab as Adjuvant Therapy in Patients with High-Risk Muscle-Invasive Urothelial Carcinoma Purpose Researchers want to see if adding autogene cevumeran to
-
The Ming Li Lab
… Primary Papers M.H. Do, W. Shi, L. Ji, E. Ladewig, X. Zhang, R.M. Srivastava, K.J. Capistrano, C. Edwards, I. Malik, B.G. Nixon, E.G. Stamatiades, M. Liu, S. Li, P. Li, C. Chou, K. Xu, T.W. Hsu, X. Wang, T.A. Chan, C.S. Leslie, M.O. Li.Reprogramming Tumor-Associated Macrophages to Outcompete Endovascular
-
2020 Annual Report
Resilient. Resourceful. Dedicated. The year 2020 was like no other. Read how the MSK community rose up to meet every moment of the year with strength, perseverance, and total commitment to exceptional cancer care, research, and education.
… Meeting the Moment MSK 2020 Annual Report Yaihara Fortis Santiago Yaihara Fortis Santiago, Associate Director, Office of Postdoctoral Affairs & Trainee Diversity Resilient. Resourceful. Dedicated. For more than 135 years, Memorial Sloan Kettering has always cared for patients with compassion and cutting-edge
-
When surgery alone is not likely to be an effective cure, our doctors may recommend a combination of radiation therapy, chemotherapy, or hormonal therapy.
… We treat many cases of cervical cancer with surgery alone. However, there are women with disease that has started to spread, or who have tumors with high-risk features, for which we recommend additional measures such as radiation therapy and/or chemotherapy, a systemic treatment that kills cancer cells
-
Technology Development
… SK 779 Description SK-MEL-2 is one of a series of melanoma cell lines established from patient-derived tumor samples. This cell line expresses wildtype B-Raf and mutant N-Ras (Q61R). Source This cell line was established in 1972 from a metastatic site on the thigh of a 60-year-old Caucasian male with
-
-
The Derek Tan Lab
… Job Title Postdoctoral Fellow Scientist, 2025–present Roche Sequencing Solutions Seattle, Washington PhD, TU Dortmund University, 2021 with Prof. Herbert Waldmann Max Planck Institute of Molecular Physiology MSc, Ruhr University of Bochum, 2017 with Prof. Frank Schulz Faculty of Chemistry & Biochemistry
-
News
Learn how new clinical trials at MSK are helping make cancer care at home a reality.
… Monday, June 3, 2024 Robert Daly, MD, MBA, a thoracic oncologist at Memorial Sloan Kettering, presented important new research about delivering high quality cancer care at home during the 2024 ASCO conference, the nation’s premier cancer conference. This research focuses on incorporating telemedicine